MedinCell S.A. (MEDCL.PA)
| Previous close | 13.40 |
| Open | 13.40 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 13.16 - 13.54 |
| 52-week range | 5.25 - 17.50 |
| Volume | |
| Avg. volume | 124,012 |
| Market cap | 389.152M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Euronext Paris Showcases Three Growth Companies With High Insider Ownership
Amid a generally positive trend in European markets, with France's CAC 40 Index recently climbing by 1.67%, investors are showing renewed confidence in the region's economic stability and growth prospects. In this context, exploring growth companies with high insider ownership on Euronext Paris could offer valuable insights into firms that combine robust market potential with strong internal commitment.
- Simply Wall St.
Euronext Paris Growth Leaders With High Insider Stakes In June 2024
As the French market shows resilience with the CAC 40 Index climbing by 1.67%, investors are keenly observing trends and opportunities within this buoyant environment. In such a market, growth companies with high insider ownership can be particularly compelling, as this often signals confidence from those who know the company best.
- Simply Wall St.
Euronext Paris Growth Companies With High Insider Ownership And At Least 28% Earnings Growth
Amidst a backdrop of moderate gains and optimistic monetary policies across European markets, France's CAC 40 Index notably advanced by 1.67%, reflecting a broader positive sentiment. In such an environment, growth companies with high insider ownership in France present a compelling profile, potentially benefiting from aligned interests between management and shareholders and robust earnings growth.
